Navigation Links
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma
Date:11/13/2013

WHITE PLAINS, N.Y., Nov. 13, 2013 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with mantle cell lymphoma (MCL) is a significant advance for patients with this blood cancer.  It was approved as a single agent for treatment of patients with MCL who have received at least one prior therapy.

Ibrutinib is the second drug with "breakthrough therapy designation" to receive FDA approval. Ibrutinib is a therapy that  targets an enzyme, Bruton's tyrosine kinase (BTK), which promotes growth of  B-cell cancers, including MCL, chronic lymphocytic leukemia (CLL), Waldenstrom's macroglobulinemia (WM), follicular lymphoma, diffuse large B-cell lymphoma, hairy cell leukemia (HCL) and multiple myeloma.

"After the FDA earlier this year designated ibrutinib as a breakthrough therapy for patients with certain forms of blood cancers, we were all hopeful that it was only a matter of time before the therapy was approved to treat these patients, who have few good treatment options," said John Walter, president and CEO of The Leukemia & Lymphoma Society (LLS).

LLS is eager to learn the outcome of FDA's ongoing review of ibrutinib for patients with chronic lymphocytic leukemia (CLL) and Waldenstrom's macroglobulinemia (WM).

"Many patients with MCL and other B-cell cancers do not respond well to standard therapies and new treatments such as ibrutinib are urgently needed," said Louis J. DeGennaro, Ph.D., LLS chief mission officer.  "LLS exists to find cures and ensure access to treatments for blood cancer patients, and any new advance that brings the potential to help save more lives is good news."

LLS funding has supported clinical trials and laboratory studies of ibrutinib for patients with CLL, and more recently for patients with HCL. John C. Byrd, M.D.,
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Polaris Group Announces Treatment of First Patient in Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
2. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
3. The Leukemia & Lymphoma Society Issues Statement Regarding the Status of Iclusig (Ponatinib)
4. The Leukemia & Lymphoma Society and the Knight Cancer Institute Launch Groundbreaking Collaboration to Improve Outcomes for Acute Myeloid Leukemia Patients
5. OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017
6. St. Jude Childrens Research Hospital study yields new strategy against high-risk leukemia
7. The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $200 Million
8. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
9. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
11. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014  When it comes to diabetes supplies, innovations ... But Timesulin happens to answer a real medical need. ... on the market, Timesulin shows how long it,s been ... from missed or double insulin doses. Very easy to ... on the insulin pen after an injection. There is ...
(Date:8/26/2014)... ANDOVER, Mass. , Aug. 26, 2014 Acelleron ... and Eatontown, N.J ., is expanding.  Acelleron, ... Fitness to form a new division, Acelleron Maternal Health & ... their clients by providing a full range of resources for ... has been named the director of maternal wellness. Vecchi, ...
(Date:8/26/2014)... , Aug. 26, 2014 SynCardia Systems, Inc., ... high on the Inc. 5000 named by the business ... world,s only FDA, Health Canada and CE approved Total ... a matching donor heart transplant," says Michael P. ... the standard of care for patients dying from end-stage ...
Breaking Medicine Technology:Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2
... Oct. 13 Cellectis bioresearch, a specialist in ... today announced that it has established a US ... Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. ... Cellectis bioresearch products and services. Cellectis ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a ... to release its third quarter 2010 financial results on Thursday, ... financial markets.  The Company will also host a conference call ... 4, 2010 to discuss its financial results and provide an ...
Cached Medicine Technology:Cellectis bioresearch Announces Establishment of Subsidiary in the US 2Cellectis bioresearch Announces Establishment of Subsidiary in the US 3Watson to Host Conference Call and Webcast to Discuss Third Quarter 2010 Earnings 2
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 A ... this month found that the dental community disagrees ... confusion for their patients. Analysis of dental advice suggested ... “correct,” with no one technique more popular than the ... disease is to brush and floss your teeth regularly,” ...
(Date:8/27/2014)... Ontario, Canada (PRWEB) August 27, 2014 ... a huge transformation as was revealed in a survey ... survey were not just surprising but astonishing as well, ... carried out online interviewed existing members on the 10yeargap ... , According to Kaly, 10yeargap marketing department manager," there ...
(Date:8/27/2014)... 2014 ALS Insights is a dedicated ... comfort. It features a series of compelling interviews with ... share their insights, in searing honesty, about issues such ... on children, what happened in the final days and ... has created a dramatic increase in public awareness and ...
(Date:8/27/2014)... AttorneyOne.com, a recognized authority on law, update ... the FDA on Organic Raw Carob Powder . ... Raw Carob Powder sold from March 12, 2014 through ... possible contamination with Salmonella. , Salmonella can cause serious, ... healthy people it can cause abdominal pain, vomiting, nausea, ...
(Date:8/27/2014)... Springs, Texas (PRWEB) August 27, 2014 ... different health IT systems, and each one they add ... projects for the IT/IS team to manage. Kaweah Delta ... preferring to work with a few vendors who offer ... In keeping with this initiative, Kaweah Delta selected ...
Breaking Medicine News(10 mins):Health News:Americans Confused About How to Brush Teeth 2Health News:Survey Reveals Younger Women Dating Older Men 2Health News:Survey Reveals Younger Women Dating Older Men 3Health News:ALS Insights Launched as Web Resource of Interviews and Information 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Kaweah Delta Health Care District Selects Access to Provide Paperless E-Forms and Electronic Patient Signatures 2Health News:Kaweah Delta Health Care District Selects Access to Provide Paperless E-Forms and Electronic Patient Signatures 3
... youth, Joshua Lavoie, offered to donate nearly 60% of his liver ... apparently did not have any// second thoughts about donating his liver, ... been suffering hepatitis C for almost two decades, which had completely ... failing liver, other than a liver transplant., ,"If he ...
... Prakash, a Harley Street plastic surgeon plans to sell a ... and his wife “look years younger”.// ,He asserts ... removed wrinkles, and made his wife, Nanthini, 48, look young ... and his wife have been taking regular injections of it ...
... filmmaker Prakash Jha and Bollywood actor-turned-politician Shatrughan Sinha, now popular talk ... invest in his// home state - Bihar. ,Suman ... here in memory of his son Ayush who died of a ... that he has put forward a proposal to set up an ...
... U.S. Attorney Drew Wrigley told the jurors that Dru Sjodin, ... indicating that Alfonso Rodriguez Jr. was the man responsible for ... from Crookston, Minnesota, has pleaded not guilty to a charge ... of the University of North Dakota. According to prosecutors, death ...
... usage of sunscreen creams can do more damage than good. ... that it is the first time that the filters in ... ,According to Dr Kerry Hanson, a senior research scientist ... sunscreen gets beneath the surface of the epidermis that is ...
... of Health (NIH) is planning to conduct a fully sponsored ... grade from 42 middle schools are to take part //to ... reduced in the youth. ,It was explained that ... food services and physical education (PE) classes, along with activities, ...
Cached Medicine News:Health News:Look younger with HGH!! 2Health News:The fate of an accused in a murder case to be decided 2Health News:Sunscreen creams – use them appropriately 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: